In recent years, congestive heart failure (CHF), acute myocardial infarction (AMI), chronic obstructive pulmonary disease (COPD), pneumonia (PN), and type 2 diabetes (DB) have become the top most costly hospitalized conditions in the United States [1]. The majority of these conditions are characterized by longer than national average length of stay (LOS) of 4.5 days [2]. Moreover, in 2013, the number of hospitalizations for these conditions equaled 3.621 million stays (10.2% of inpatient admissions) [1]. Likewise, the average inpatient treatment costs incurred for these conditions were